Effect of travoprost, latanoprost and bimatoprost PGF2α treatments on the biomechanical properties of in-vivo rabbit cornea. (February 2022)

• Record Type: Journal Article
• Authors: Wang, JunJie; Zhao, YiPing; Yu, AYong; Wu, Jie; Zhu, ManMan; Jiang, MuChen; Li, Xuefei; Zhu, DaTian; Zhang, PeiPei; Zheng, XiaoBo; Bao, FangJun; Elsheikh, Ahmed
• Is Part Of: Experimental eye research. Volume 215(2022)
• Publication Date: 2022-02
• Subjects: Prostaglandin -- Cornea -- Biomechanics; Ophthalmology -- Periodicals; Eye -- Periodicals; Œil -- Périodiques; Ophthalmology; Periodicals; Electronic journals; 612.8405
• DOI: 10.1016/j.exer.2022.108920
• Languages: English
• ISSNs: 0014-4835

Abstract

Abstract: Prostaglandin F2α analogues (PGF2α), one of the most commonly prescribed classes of hypotensive agents, could decrease collagen fibril density and remodel the extracellular matrix in cornea. We hypothesized that PGF2α′s would induce corneal softening, reduce the accuracy of intraocular pressure (IOP) measurement and lead to uncertainty in the effectiveness of the therapy. We determined the stress-strain behavior of rabbit cornea after PGF2α usage and evaluated the effect of biomechanical changes associated with PGF2α treatment on IOP measurements by Goldmann Applanation Tonometry (GAT). The tangent modulus decreased after PGF2α treatment, while the stromal interfibrillar spacing increased. PGF2α was shown to also affect the lateral eye with lower effect, which did not undergo direct eyedrop treatment. Significant decreases in the numerical predictions of GAT-IOP were predicted in all treated groups relative to control groups. Different PGF2α′s (travoprost, latanoprost and bimatoprost) were associated with different extents of reduction in tissue stiffness and changes in corneal microstructure. PGF2α-induced changes in corneal mechanical properties could reduce the accuracy of IOP measurement and may cause an overestimation of the effect of PGF2α in lowering IOP, possibly leading to uncertainties in glaucoma management. Highlights: PGF2α may reduce corneal material stiffness and thus lead to an overestimation of its effect in lowering IOP